Gevorg Tamamyan Received the SLACOM 2026 Award for Global Oncology Leadership – IMMONC
Immune Oncology Research Institute / X

Gevorg Tamamyan Received the SLACOM 2026 Award for Global Oncology Leadership – IMMONC

Immune Oncology Research Institute (IMMONC) shared a post on X:

“Proud to share that our CEO, Gevorg Tamamyan , received the SLACOM 2026 Award for Global Oncology Leadership for his contributions to pediatric oncology and global cancer collaboration.

Congratulations on this remarkable achievement!”

Other articles featuring Immune Oncology Research Institute on OncoDaily.